Clinical observation of plasma exchange and plasma perfusion on treating chronic hepatitis patients with severe jaundice
Chen Mei-zh
Abstract
Chen Mei-zh
Abstract
Objective To study the therapeutic effect of plasma exchange and plasma perfusion(PE+PP)on chronic hepatitis patients with severe jaundice. Methods Seventy-two patients with severe jaundice were divided into two groups randomly. In the treating group, the patients were treated with (PE+PP) on the basis of the conventional therapy, but the control group received the conventional therapy only. The main symptoms, liver function, prothrombin activity(PTA) before and 2 weeks, 4 weeks after treatment, were observed. Results After treating with (PE+PA), the liver function were ameliorated. The prothrombin activity increased significantly. 2 weeks, 4 weeks after treatment, the level of total bilirubin decreased markedly(P 0.01),the prothrombin activity increased significantly(P 0.05). The total effective rate in the treating group was 89.2%, while 71.4% in the control group. There were significant differences between the two group(sP 0.01). Conclusion Artificial liver support system can ameliorate the liver function of chronic with hepatitis patients severe jaundice. It can also increase the survival rate.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To study the therapeutic effect of plasma exchange and plasma perfusion(PE+PP)on chronic hepatitis patients with severe jaundice. Methods Seventy-two patients with severe jaundice were divided into two groups randomly. In the treating group, the patients were treated with (PE+PP) on the basis of the conventional therapy, but the control group received the conventional therapy only. The main symptoms, liver function, prothrombin activity(PTA) before and 2 weeks, 4 weeks after treatment, were observed. Results After treating with (PE+PA), the liver function were ameliorated. The prothrombin activity increased significantly. 2 weeks, 4 weeks after treatment, the level of total bilirubin decreased markedly(P 0.01),the prothrombin activity increased significantly(P 0.05). The total effective rate in the treating group was 89.2%, while 71.4% in the control group. There were significant differences between the two group(sP 0.01). Conclusion Artificial liver support system can ameliorate the liver function of chronic with hepatitis patients severe jaundice. It can also increase the survival rate.
Key concepts: Medicine, Jaundice, Gastroenterology, Internal medicine, Prothrombin time, Hepatitis a virus, Liver function, Perfusion